CMC @1098 (100.0%) on 21-jan-2018 [ CHARS 3.50796 POS=NNS 1.96998 FULL_POS=JJ_NNS 1.66188 LASTSUFFIX=ns 1.11819 LASTSUFFIX=ions 1.08624 PREFIX=rea 1.00665 LASTSUFFIX=tions 0.95077 FULL_WORDSHAPE=a_a -0.87706 SHORT_WORDSHAPE=Aa -1.49527 WORDS -5.55159 ] using allergic_reactions
CPL @1097 (82.8%) on 19-jan-2018 [ "_ usually pass within" "_ including urticaria" "_ include headaches" "_ involving the skin" "_ include difficulty" "_ including rash" "_ include breathing problems" "_ are dose dependent" "_ are life-threatening" "_ including fever" "_ have also been reported with" "_ include fever" "_ have occurred with" "_ including rashes" "_ include difficulty breathing" "_ including swelling of" "_ include symptoms" "_ include redness" "_ include abdominal pain" "_ include nausea" "_ are usually mild" "_ including anaphylaxis" "_ include skin rashes" "_ including redness" "_ include ataxia" "_ are aggravated by" "_ are also observed in" "_ are rash" "_ including asthma" "_ include watery eyes" "_ including skin rash" "_ usually occur after" "_ usually appear within" "_ have been reported rarely with" "_ include hives" "_ include skin rash" "_ reported with" "_ including anaphylactic shock" "_ become increasingly severe" "_ affecting the skin" "_ usually occur within" "_ including hives" "_ include rashes" "_ generally appear within" "_ have been reported with" "_ worsen over" "_ include breathing difficulty" "_ included difficulty breathing" "_ including angioedema" "_ include eye redness" "_ usually begin within" "_ include severe" "_ including itching" "_ are often mild" "_ typically occur within" "_ usually occur during" "_ include swelling of" "_ following injection" "_ include rash" "_ have been reported after" "_ typically appear within" "_ include a rash" "_ including irritation" "_ include urticaria" "_ including skin rashes" "_ get worse" ] using allergic_reactions
relations
NELL has only weak evidence for items listed in grey